OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Hematology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Posttransplant cyclophosphamide: a universal graft versus host disease prophylaxis	27
Novel blood derived hemostatic agents for bleeding therapy and prophylaxis	26
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia	23
Deficits in our understanding of natural killer cell development in mouse and human	23
Heme- and iron-activated macrophages in sickle cell disease: an updated perspective	22
Interferon regulatory factor-8-dependent innate immune alarm senses GATA2 deficiency to alter hematopoietic differentiation and function	19
Disparities in acute myeloid leukemia treatments and outcomes	18
Adenosine signaling in promoting the balance between erythropoiesis and myelopoiesis	18
Megakaryocytes as mitochondria factories: potential donors for mitochondria transplantation	18
Mesenchymal stromal cells: an update	18
Developmental regulation of primitive erythropoiesis	18
Limitations of rituximab in treating primary immune thrombocytopenia and the therapeutic potentials of alternatives	17
Platelet lifespan and mechanisms for clearance	16
Unraveling lipid metabolism for acute myeloid leukemia therapy	16
The impact of obesity-induced inflammation on clonal hematopoiesis	16
Editorial introductions	15
Humanized murine models of platelet function	13
Multifaceted roles of CRISPR technology in blood cancer research	13
Shared host, distinct invaders: metabolomic footprints of plasmodium and babesia in host red cells	12
High-throughput genotyping tools for red blood cell antigens	11
Advances on the genetic basis of red cell membrane disorders	10
Editorial introduction	10
Haematopoietic stem cell quiescence exposed using mitochondrial membrane potential	10
Hemostatic abnormalities in acute promyelocytic leukemia: clinical implications and mechanisms	10
Targeting hemostatic enzymes: from mechanistic insights to therapeutic frontiers	9

Red cells: not only hemoglobin – plasma membranes are also of paramount importance	8
Signaling mechanisms and cis-regulatory control of Samd14 in erythroid regeneration	8
Editorial introductions	8
Tissue factor pathway inhibitor – cofactor-dependent regulation of the initiation of coagulation	8
Understanding and targeting erythroid progenitor cells for effective cancer therapy	8
Cellular contributions to the pathogenesis of anti-platelet factor 4 disorders	8
Venous thromboembolism: diagnostic advances and unaddressed challenges in management	7
Translation defects in ribosomopathies	7
Current Opinion in Hematology	7
Platelets in vascular inflammation: fire-fighters or pyromaniacs?	7
Modelling arterial thrombus formation in vitro	7
The immunology of PF4 polyanion interactions	7
Editorial introductions	7
Update on preclinical and clinical efforts on ex-vivo expansion of hematopoietic stem and progenitor cells	7
Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods	7
A role of platelet C-type lectin-like receptor-2 and its ligand podoplanin in vascular biology	6
Challenges and opportunities in shared care for international patients treated with cellular therapy for nonmalignant disease	6
Immunomodulatory roles of red blood cells	6
Chediak-Higashi syndrome	6
Platelets and platelet–leukocyte interactions in infectious diseases	6
Models to study myelodysplastic syndrome and acute myeloid leukaemia	6
Red blood cell changes due to cancer and cancer treatments: a narrative review	6
PROTACs in platelets: emerging antithrombotic strategies and future perspectives	6
Editorial introduction	6
The state of prediction models in hematologic disease: a worrisome assessment	6